Sept 14 (Reuters) – Spectrum Pharmaceuticals Inc’s
experimental bladder cancer treatment apaziquone is not
effective in delaying the time to recurrence of the disease, an
advisory committee to the…
The post Spectrum bladder cancer drug not effective – U.S. FDA panel appeared first on NASDAQ.